Showing results (51-60 of 195) with videos related to
Sort By:
Pageof 20
Diabetes Care|February 28, 2014
Racial disparity of eye examinations among the U.S. working-age population with diabetes: 2002-2009Qian Shi, Yingnan Zhao, Vivian Fonseca, et al.Diabetes Care|May 27, 2003
Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic controlVivian Fonseca, George Grunberger, Shamita Gupta, et al.Expert Review of Pharmacoeconomics & Outcomes Research|January 28, 2012
Economic burden of hypoglycemia in patients with Type 2 diabetesShuqian Liu, Yingnan Zhao, James M Hempe, et al.Diabetes Research and Clinical Practice|February 18, 2014
Genital and urinary tract infections in diabetes: impact of pharmacologically-induced glucosuriaSuzanne Geerlings, Vivian Fonseca, David Castro-Diaz, et al.Annals of Epidemiology|September 24, 2004
Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III)Paul Muntner, Jiang He, Jing Chen, et al.Diabetes, Obesity & Metabolism|July 8, 2022
Predicting incident heart failure among patients with type 2 diabetes mellitus: The DM-CURE risk scoreYilu Lin, Hui Shao, Lizheng Shi, et al.Journal of the Endocrine Society|June 11, 2025
Long-Term Testosterone Shows Cardiovascular Safety in Men With Testosterone Deficiency in Electronic Health RecordsYilu Lin, Shaveta Gupta, Lizheng Shi, et al.Health and Quality of Life Outcomes|September 15, 2010
Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysisLizheng Shi, Jinan Liu, Vivian Fonseca, et al.Pain Practice : the Official Journal of World Institute of Pain|September 29, 2011
Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective studyYingnan Zhao, Jinan Liu, Yang Zhao, et al.The Journal of Clinical Endocrinology and Metabolism|November 27, 2019
Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN TrialsCyrus DeSouza, Bertrand Cariou, Satish Garg, et al.Pageof 20